サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631257

低中所得国向けオピオイド代替療法の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

Low and Middle Income Countries Opioid Substitution Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日
ページ情報
英文 200 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.06円
低中所得国向けオピオイド代替療法の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）
出版日: 2025年01月10日
発行: Fairfield Market Research
ページ情報: 英文 200 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

低中所得国向けオピオイド代替療法（OST）の市場規模は7.20%のCAGRで拡大し、2025年の8億5,560万米ドルから2032年には13億9,100万米ドルに拡大すると予測されています。OSTは、違法なオピオイドをメサドンやブプレノルフィンのような医学的に管理された代替薬に置き換えることで、害を減らし、個人の依存症克服を支援します。OSTは、過剰摂取、血液媒介性疾患のトランスミッション、その他の合併症のリスクを最小化すると同時に、社会復帰を支援します。

低中所得国では、OSTはオピオイドの誤用に関連する公衆衛生上の課題に対処するために不可欠です。市場の成長には、OSTの有効性に対する認識の高まり、国際的・政府的支援、サービス提供の革新が寄与しています。市場参入者にとっての機会としては、文化的に適切なOSTソリューションを構築するためのヘルスケアプロバイダーとの提携や、十分なサービスを受けていない地域でのアクセス拡大のための遠隔医療の活用などがあります。

低中所得国向けオピオイド代替療法市場は、公衆衛生上の懸念としてのオピオイド中毒の認識の高まりにより成長を続けています。政府や国際機関の支援がOSTプログラムの実施を後押ししています。市場参加者は、アクセスしやすく地域に特化したソリューションを提供するために協力し、患者の転帰を向上させるために技術を取り入れることで、機会を生かすことができます。

当レポートでは、低中所得国向けオピオイド代替療法市場について調査し、市場の概要とともに、薬剤クラス別、適応症別、流通チャネル別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • 経済概要
  • PESTLE分析

第3章 価格分析、2019年～2023年

第4章 低中所得国向けオピオイド代替療法市場の見通し、2019年～2032年

  • 低中所得国向けオピオイド代替療法市場の見通し、薬剤クラス別、規模（100万米ドル）、数量（件）、2019年～2032年
  • 低中所得国向けオピオイド代替療法市場の見通し、適応症別、規模（100万米ドル）、数量（件）、2019年～2032年
  • 低中所得国向けオピオイド代替療法市場の見通し、流通チャネル別、規模（100万米ドル）、数量（件）、2019年～2032年
  • 低中所得国向けオピオイド代替療法市場の見通し、地域別、規模（100万米ドル）、数量（件）、2019年～2032年

第5章 北米の低中所得国向けオピオイド代替療法市場の見通し、2019年～2032年

第6章 欧州の低中所得国向けオピオイド代替療法市場の見通し、2019年～2032年

第7章 アジア太平洋の低中所得国向けオピオイド代替療法市場の見通し、2019年～2032年

第8章 ラテンアメリカの低中所得国向けオピオイド代替療法市場の見通し、2019年～2032年

第9章 中東・アフリカの低中所得国向けオピオイド代替療法市場の見通し、2019年～2032年

第10章 競合情勢

  • ソリューションタイプ別と適応症別ヒートマップ
  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • Indivior Inc.
    • Alkermes, Inc
    • Mundipharma GmbH
    • Viatris Inc
    • Intas Pharmaceuticals
    • Camurus

第11章 付録

目次

The global Low and Middle Income Countries Opioid Substitution Therapy (OST) Market is projected to grow at a CAGR of 7.20%, increasing from US$ 855.6 million in 2025 to US$ 1,391 million by 2032. OST involves replacing illicit opioids with medically supervised alternatives like methadone or buprenorphine, reducing harm and supporting individuals in overcoming addiction. OST minimizes risks of overdose, blood-borne disease transmission, and other complications while aiding reintegration into society.

In LMICs, OST is vital for addressing public health challenges linked to opioid misuse. The market's growth is fueled by rising awareness of OST's effectiveness, international and governmental support, and innovations in service delivery. Opportunities for market players include partnerships with healthcare providers to create culturally appropriate OST solutions and leveraging telemedicine to expand access in underserved areas.

The OST market in LMICs continues to grow due to increased recognition of opioid addiction as a public health concern. Government and international organization support has bolstered OST program implementation. Market players can capitalize on opportunities by collaborating to deliver accessible, region-specific solutions and incorporating technology to enhance patient outcomes.

Market Growth Drivers

1.Recognition of Public Health Impact

Governments and international health organizations increasingly recognize the burden of opioid addiction. This has led to proactive strategies, with OST emerging as a key harm reduction tool benefiting individuals and communities.

2.Policy Support and Collaboration

Collaborative efforts between governments, NGOs, and international organizations have promoted OST adoption. Supportive policies and integration into healthcare systems ensure broader program reach and impact.

3.Rising Awareness and Healthcare Investments

Increased awareness about opioid addiction and societal impacts, along with healthcare infrastructure investments, drive market growth. Advocacy campaigns promote harm reduction strategies and OST acceptance.

Market Restraints

1.Regulatory Challenges

Diverse regulatory frameworks across LMICs create significant hurdles. Variations in licensing, medication restrictions, and government support hinder OST adoption. Harmonizing regulations is critical for market growth.

2.Implementation Barriers

Limited healthcare infrastructure and insufficient provider training challenge effective OST deployment. Addressing these barriers requires capacity-building initiatives and strategic collaborations.

Business Opportunities

1.Telemedicine Expansion

Telemedicine can improve OST access in regions with limited healthcare infrastructure. Remote consultations and support services address geographical barriers, ensuring consistent care delivery.

2.Strategic Collaborations

Partnerships with healthcare providers, NGOs, and governments can enhance OST delivery. Collaborative efforts like training programs and awareness campaigns foster sustainable healthcare ecosystems.

3.Technological Innovations

Advanced OST solutions tailored to regional needs, such as digital tools for monitoring adherence, present growth potential. Investing in technology-driven systems can improve outcomes and expand market reach.

Regional Analysis

1.Europe

Europe leads the LMICs OST market with progressive harm reduction strategies and strong healthcare systems. Evidence-based policies and collaborations ensure widespread OST adoption. Europe's focus on personalized care and harm reduction establishes it as a model for managing opioid dependence effectively.

2.South Asia and the Pacific

South Asia and the Pacific is the fastest-growing region, driven by health policies and increasing public awareness. Government initiatives, international collaborations, and recognition of OST benefits position this region for rapid expansion.

3.Latin America, Middle East & Africa

Emerging markets in these regions offer untapped opportunities. Increased government efforts and growing investments in healthcare infrastructure drive OST adoption.

Competitive Analysis

Key players in the OST Market include:

  • Indivior Inc.
  • Alkermes, Inc.
  • Mundipharma GmbH
  • Viatris Inc.
  • Intas Pharmaceuticals
  • Camurus

These companies focus on innovation, collaborations, and targeted regional strategies to strengthen their market positions.

Low and Middle Income Countries Opioid Substitution Therapy Market Segmentation

1.By Drug Class

  • Opioid Antagonists
  • Naloxone
  • Naltrexone
  • Opioid Agonists and Partial Agonists
  • Methadone
  • Buprenorphine

2.By Indication

  • Pain Management
  • Opioid Withdrawal/Opioid Use Disorder (OUD)
  • Alcohol De-addiction
  • Depression

3.By Distribution Channel

  • Government-supported Centers/NGOs/Tenders
  • Institutional Sales
  • Hospitals
  • Psychiatric Clinics
  • Retail Pharmacies
  • Online Sales

4.By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Low and Middle Income Countries Opioid Substitution Therapy Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis by Drug Class, 2019 - 2023
  • 3.2. Prominent Factor Affecting Low and Middle Income Countries Opioid Substitution Therapy Prices
  • 3.3. Global Average Price Analysis by Region

4. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

  • 4.1. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Opioid Antagonists
      • 4.1.1.2. Naloxone
      • 4.1.1.3. Naltrexone
      • 4.1.1.4. Opioid Agonists and Partial Agonists
      • 4.1.1.5. Methadone
      • 4.1.1.6. Buprenorphine
  • 4.2. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Pain Management
      • 4.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
      • 4.2.1.3. Alcohol De-addiction
      • 4.2.1.4. Depression
  • 4.3. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Government-supported Centers/NGO's/Tenders
      • 4.3.1.2. Institutional Sales
      • 4.3.1.3. Hospitals
      • 4.3.1.4. Psychiatric clinics
      • 4.3.1.5. Retail Pharmacies
      • 4.3.1.6. Online Sales
  • 4.4. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

  • 5.1. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Opioid Antagonists
      • 5.1.1.2. Naloxone
      • 5.1.1.3. Naltrexone
      • 5.1.1.4. Opioid Agonists and Partial Agonists
      • 5.1.1.5. Methadone
      • 5.1.1.6. Buprenorphine
  • 5.2. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Pain Management
      • 5.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
      • 5.2.1.3. Alcohol De-addiction
      • 5.2.1.4. Depression
  • 5.3. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Government-supported Centers/NGO's/Tenders
      • 5.3.1.2. Institutional Sales
      • 5.3.1.3. Hospitals
      • 5.3.1.4. Psychiatric clinics
      • 5.3.1.5. Retail Pharmacies
      • 5.3.1.6. Online Sales
    • 5.3.2. Attractiveness Analysis
  • 5.4. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 5.4.1.2. U.S. Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 5.4.1.3. U.S. Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 5.4.1.4. Canada Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 5.4.1.5. Canada Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 5.4.1.6. Canada Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

6. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

  • 6.1. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Opioid Antagonists
      • 6.1.1.2. Naloxone
      • 6.1.1.3. Naltrexone
      • 6.1.1.4. Opioid Agonists and Partial Agonists
      • 6.1.1.5. Methadone
      • 6.1.1.6. Buprenorphine
  • 6.2. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Pain Management
      • 6.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
      • 6.2.1.3. Alcohol De-addiction
      • 6.2.1.4. Depression
  • 6.3. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Government-supported Centers/NGO's/Tenders
      • 6.3.1.2. Institutional Sales
      • 6.3.1.3. Hospitals
      • 6.3.1.4. Psychiatric clinics
      • 6.3.1.5. Retail Pharmacies
      • 6.3.1.6. Online Sales
    • 6.3.2. Attractiveness Analysis
  • 6.4. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.2. Germany Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.3. Germany Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.4. U.K. Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.5. U.K. Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.6. U.K. Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.7. France Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.8. France Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.9. France Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.10. Italy Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.11. Italy Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.12. Italy Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.13. Turkey Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.14. Turkey Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.15. Turkey Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.16. Russia Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.17. Russia Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.18. Russia Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.19. Rest of Europe Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.20. Rest of Europe Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 6.4.1.21. Rest of Europe Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

7. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Opioid Antagonists
      • 7.1.1.2. Naloxone
      • 7.1.1.3. Naltrexone
      • 7.1.1.4. Opioid Agonists and Partial Agonists
      • 7.1.1.5. Methadone
      • 7.1.1.6. Buprenorphine
  • 7.2. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Pain Management
      • 7.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
      • 7.2.1.3. Alcohol De-addiction
      • 7.2.1.4. Depression
  • 7.3. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Government-supported Centers/NGO's/Tenders
      • 7.3.1.2. Institutional Sales
      • 7.3.1.3. Hospitals
      • 7.3.1.4. Psychiatric clinics
      • 7.3.1.5. Retail Pharmacies
      • 7.3.1.6. Online Sales
    • 7.3.2. Attractiveness Analysis
  • 7.4. Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.2. China Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.3. China Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.4. Japan Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.5. Japan Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.6. Japan Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.7. South Korea Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.8. South Korea Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.9. South Korea Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.10. India Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.11. India Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.12. India Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.13. Southeast Asia Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.14. Southeast Asia Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.15. Southeast Asia Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.16. Rest of Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.17. Rest of Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 7.4.1.18. Rest of Asia Pacific Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

8. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

  • 8.1. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Opioid Antagonists
      • 8.1.1.2. Naloxone
      • 8.1.1.3. Naltrexone
      • 8.1.1.4. Opioid Agonists and Partial Agonists
      • 8.1.1.5. Methadone
      • 8.1.1.6. Buprenorphine
  • 8.2. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Pain Management
      • 8.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
      • 8.2.1.3. Alcohol De-addiction
      • 8.2.1.4. Depression
  • 8.3. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Government-supported Centers/NGO's/Tenders
      • 8.3.1.2. Institutional Sales
      • 8.3.1.3. Hospitals
      • 8.3.1.4. Psychiatric clinics
      • 8.3.1.5. Retail Pharmacies
      • 8.3.1.6. Online Sales
    • 8.3.2. Attractiveness Analysis
  • 8.4. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.2. Brazil Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.3. Brazil Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.4. Mexico Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.5. Mexico Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.6. Mexico Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.7. Argentina Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.8. Argentina Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.9. Argentina Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.10. Rest of Latin America Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.11. Rest of Latin America Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 8.4.1.12. Rest of Latin America Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

9. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Opioid Antagonists
      • 9.1.1.2. Naloxone
      • 9.1.1.3. Naltrexone
      • 9.1.1.4. Opioid Agonists and Partial Agonists
      • 9.1.1.5. Methadone
      • 9.1.1.6. Buprenorphine
  • 9.2. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Pain Management
      • 9.2.1.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
      • 9.2.1.3. Alcohol De-addiction
      • 9.2.1.4. Depression
  • 9.3. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Government-supported Centers/NGO's/Tenders
      • 9.3.1.2. Institutional Sales
      • 9.3.1.3. Hospitals
      • 9.3.1.4. Psychiatric clinics
      • 9.3.1.5. Retail Pharmacies
      • 9.3.1.6. Online Sales
    • 9.3.2. Attractiveness Analysis
  • 9.4. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.2. GCC Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.3. GCC Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.4. South Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.5. South Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.6. South Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.7. Egypt Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.8. Egypt Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.9. Egypt Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.10. Nigeria Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.11. Nigeria Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.12. Nigeria Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.13. Rest of Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Drug Class, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.14. Rest of Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2032
      • 9.4.1.15. Rest of Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032

10. Competitive Landscape

  • 10.1. By Solution Type vs by Indication Heatmap
  • 10.2. Company Market Share Analysis, 2024
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Indivior Inc.
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Alkermes, Inc
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. Mundipharma GmbH
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Viatris Inc
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Intas Pharmaceuticals
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Camurus
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations